Disclaimer: That Intended For Medical Professionals Only
AjantaMed Dialogue
Stay Informed, Stay Ahead
Latest News :
New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management • New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management •
sticky-medbot
VKC & Lifitegrast : Clinical Experience- Lifanta Ocular Surface

VKC & Lifitegrast : Clinical Experience- Lifanta Ocular Surface

Vernal Keratoconjunctivitis (VKC) is a chronic, inflammatory ocular surface disease that significantly impacts patient comfort and quality of life.

 

This video presents real-world clinical experience with Lifitegrast (Lifanta) in managing ocular surface inflammation associated with VKC.

By : Dr. Eric Donnenfled

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.